College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP Reference Resources and Publications > CAP TODAY > CAP TODAY 2006 Archive > FDA-cleared cardiac CRP assays
Printable Version

  FDA-cleared cardiac CRP assays





cap today



August 2006
Feature Story

Anne Paxton

As of July 2006, the FDA has cleared eight hsCRP assays for cardiac risk assessment:

  • Stratus CS Acute Care CardioPhase HSCRP Test-Pak, Dade Behring Inc.
  • C-Reactive Protein (Latex) High Sensitive Test System for Cobas Integra Instruments, Roche Diagnostics Corp.
  • Dimension CardioPhase High Sensitivity CRP Flex reagent cartridge, Dade Behring Inc.
  • Olympus CRP Latex Immunoturbidimetric Reagent and Calibrators, Osr6199; Olympus Crp L, Olympus America Inc.
  • Tina-Quant RP (Latex) HS, Roche Diagnostics Corp.
  • Vitros Chemistry Products hsCRP Reagent, Vitros C, Ortho-Clinical Diagnostics Inc.
  • Olympus CRP Latex Immunoturbidimetric Reagent, Olympus America Inc.
  • N High Sensitivity CRP, Dade Behring Inc.

Other applications are pending. To check assays that have been cleared for cardiac risk assessment, see the FDA website. Search for NQD under the product code field.

Anne Paxton is a writer in Seattle.

bullet Related Links





 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed